Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 1
Submit an article Journal homepage
348
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma

Hua-Jay J. Chernga Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8266-8447View further author information
ORCID Icon,
Hubert H. Chuangb Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Raphael Steinerc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0003-3717-3629View further author information
ORCID Icon,
Luis Fayadc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Paolo Stratic Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Ranjit Nairc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Fredrick Hagemeisterc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Loretta J. Nastoupilc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Hun Ju Leec Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sattva S. Neelapuc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Christopher R. Flowersc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Felipe Samaniegoc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Maria Rodriguezc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Homer A. Macapinlacb Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Lei Fengd Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Jason Westinc Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-1824-2337View further author information
ORCID Icon show all
Pages 74-83 | Received 30 May 2021, Accepted 08 Aug 2021, Published online: 26 Aug 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Adrian Minson, Michael Hofman & Michael Dickinson. (2022) A PET in a time of need: toward early PET-adapted therapy in DLBCL in first relapse. Leukemia & Lymphoma 63:1, pages 1-4.
Read now

Articles from other publishers (2)

Belinda A. Campbell, Rachel Brown, Alessandro Lambertini, Michael S. Hofman, Mathias Bressel, John F. Seymour, Andrew Wirth, Michael MacManus & Michael Dickinson. (2023) Are dynamic or fixed FDG‐PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B‐cell lymphoma undergoing autologous haematopoietic stem cell transplantation?. British Journal of Haematology 201:3, pages 502-509.
Crossref
Max J. Gordon & Jason R. Westin. (2021) Innovative Approaches in Untreated DLBCL. Clinical Lymphoma Myeloma and Leukemia 21, pages S183-S185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.